USE OF THE EDMONTON INJECTOR FOR PARENTERAL OPIOID MANAGEMENT OF CANCER PAIN - A STUDY OF 100 CONSECUTIVE PATIENTS

被引：15

作者：

BRUERA, E

VELASCOLEIVA, A

SPACHYNSKI, K

FAINSINGER, R

MILLER, MJ

MACEACHERN, T

机构：

[1] Palliative Care Program, Edmonton General Hospital, University of Alberta, Edmonton, Alta.

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1993年 / 8卷 / 08期

关键词：

CANCER; PAIN; NAUSEA; EDMONTON INJECTOR;

D O I：

10.1016/0885-3924(93)90081-6

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

In this retrospective study, we reviewed the patterns of use of the Edmonton Injector (EI) in 100 consecutive cancer patients. Seventy-eight patients used the EI for an average of 23+/-27 days. The main reasons for starting the EI were nausea (37 patients) and severe pain (31 patients). The median opioid dose equivalent to parenteral morphine (MEDD) was 264+/-443 mg/day. The mean duration of the subcutaneous injection site was 6.5+/-3.2 days. The most frequent reasons for change were accidental needle pulling (59%) and erythema (12%). Only two patients developed local infection (1% of 196 sites). The average cost of treatment was $1.65 Canadian per patient per day. No mechanical problems or refusals to start or continue treatment were detected. We conclude that the EI is a safe and simple device that allows for cost-effective parenteral administration of opioids for cancer pain.

引用

页码：525 / 528

页数：4

共 12 条

[1]

Bruera, Macmillan, Hanson, MacDonald, Palliative care in a cancer center results in 1984 vs 1987, Journal of Pain and Symptom Management, 5, pp. 1-5, (1990)

[2]

Foley, The treatment of cancer pain, N Engl J Med, 313, pp. 84-95, (1985)

[3]

Kerr, Sone, De Angelis, Et al., Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients, Ann Intern Med, 108, pp. 554-557, (1988)

[4]

Ferrell, Ferrante, McCaffery, Routes of opioid administration for cancer pain: controversial issues and indications [abst], Am Pain Soc, 119, (1991)

[5]

Bruera, Macmillan, Hanson, MacDonald, The Edmonton injector: a simple device for patient-controlled subcutaneous analgesia, Pain, 44, pp. 167-169, (1991)

[6]

Bruera, Kuehn, Miller, Selmser, Macmillan, The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients, J Palliat Care, 7, pp. 6-9, (1991)

[7]

Bruera, Macmillan, Hanson, MacDonald, The Edmonton staging system for cancer pain: preliminary report, Pain, 37, pp. 203-209, (1989)

[8]

Bruera, Miller, McCallion, Macmillan, Krefting, Hanson, Cognitive failure (CF) in patients with terminal cancer: a prospective study, J Pain Symptom Manage, 7, pp. 192-195, (1992)

[9]

Bruera, Ripamonti, Alternate routes of administration of opioids for the management of cancer pain, Cancer pain, pp. 161-184, (1992)

[10]

Moulin, Johnson, Murray-Parsons, Et al., Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use, Can Med Assoc J, 146, pp. 891-897, (1992)

← 1 2 →